Macropinocytosis is an endocytic process responsible for internalizing a large amount of extracellular fluid and its content via the formation of dynamic and actin-driven plasma membrane protrusions called membrane ruffles1. Many of these membrane ruffles form cups that close and fuse back onto the cell and separate from the plasma membrane as large, heterogeneous intracellular endosomes also known as macropinosomes1. Although macropinocytosis is induced by growth factors such as macrophage colony-stimulating factor (M-CSF) and epidermal growth factor (EGF) in a wide range of cell types, an additional unique, calcium-dependent process known as constitutive macropinocytosis has been also observed in innate immune cells2,3,4,5,6,7,8.
The ability of cells to internalize extracellular material via macropinocytosis has been shown to play an important role in a variety of physiological processes ranging from nutrient uptake to pathogen capture and antigen presentation9,10,11. However, because this process is non-selective and inducible, it has also been implicated in a number of pathological conditions. Indeed, previous studies suggested that macropinocytosis plays an important role in Alzheimer's disease, Parkinson's disease, cancer, nephrolithiasis and atherosclerosis12,13,14,15,16. Moreover, certain bacteria and viruses have shown to utilize macropinocytosis to gain entry into host cells and induce infection17,18. Interestingly, stimulation of macropinocytosis can be also exploited for targeted delivery of therapeutic agents in various disease conditions19,20.
Previous studies have explored macropinocytosis by quantifying internalized fluorescently-tagged fluid-phase markers in the absence and presence of pharmacological agents that inhibit macropinocytosis using flow cytometry and confocal imaging21,22. Currently available pharmacological tools that inhibit macropinocytosis are limited to and comprise of 1) actin polymerization inhibitors (cytochalasin D and latrunculins), 2) PI3K blockers (LY-290042 and wortmannin) and 3) inhibitors of sodium hydrogen exchangers (NHE) (amiloride and EIPA)5,14,15,23,24,25. However, because these inhibitors have endocytosis independent effects, it is difficult to selectively determine the contribution of macropinocytosis to solute uptake and disease pathogenesis especially in vivo21.
Scanning electron microscopy (SEM) is a type of electron microscope that produces ultra-high-resolution images of cells using a focused beam of electrons26. In macropinocytosis research, SEM imaging is regarded as the gold standard technique to visualize topographical and morphological characteristics of the plasma membrane, quantify membrane ruffle formation, and investigate their progression towards macropinosome internalization. Furthermore, scanning electron microscopy combined with the quantification of solute uptake, in the presence and absence of macropinocytosis blockers, provides a reliable strategy to examine macropinocytotic solute internalization in vitro. This paper provides a detailed protocol on how to prepare cells for SEM, visualize the cell surface, quantify ruffle formation, and examine their progress towards cup closure and macropinosome internalization.